Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. After undergoing a new form of experimental therapy, Parkville resident Katie Pope Kopp is now in remission.
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.
Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.